Two new drugs, bedaquiline and delamanid, are proving to be the very last life-line for TB patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available.
An article published by Médecins Sans Frontières features the story of a girl with extensively drug-resistant TB being cared for by the organization in Mumbai.
To read the article, click here.
Source: Médecins Sans Frontières